RNARevive
Plug and Play · RNARevive is developing a next-generation RNA platform that enables long-lasting, low-dose protein therapeutics. Our lead candidates tackle the anti-aging and longevity space, targeting osteoporosis, age-related macular degeneration (AMD), and liver diseases.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 Ochre BioShared: liver disease, rna, developingActiveOther | Other | Active | YC +1W20 |
 Dorian TherapeuticsShared: age related, therapeutic, diseaseAcquiredOther | Other | Acquired | YCS18 |
 ProteineaShared: protein therapeutic, biotechnology, suchNot statedOther | Other | Not stated | 500 Global2020 |
 ParcelBioShared: protein therapeutic, rna, durabilityActiveOther | Other | Active | YCW24 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Persist AIShared: long lasting, disease, developingActiveAI | AI | Active | YCW23 |
 Tradewind BioScienceShared: lead candidate, therapeutic, antiActiveOther | Other | Active | YCW18 |
 LyggShared: anti agingActiveOther | Other | Active | YCW21 |
 Diapin TherapeuticsShared: liver disease, therapeutic, antiNot statedOther | Other | Not stated | Plug and Play |
 Neursantys, Inc.Shared: age related, aging, diseaseNot statedOther | Other | Not stated | Plug and Play |
Also from Plug and Play
All of Plug and Play
Programs
| Program | Cohort | Source |
|---|---|---|
 Plug and Play | Not stated | Plug and Play Page |
About RNARevive
RNArevive Therapeutics is a biotechnology company specializing in the development of a next-generation self-amplifying RNA (saRNA) platform designed to enable durable, low-dose protein therapeutics in vivo. This innovative technology addresses key challenges of traditional biologics and mRNA therapies, such as limited durability, high manufacturing costs, and frequent dosing requirements. The platform is applied across chronic and specialty disease areas, including bone health, ophthalmology, and liver diseases, aiming to reduce patient and healthcare system burdens through long-lasting protein expression. By integrating advanced RNA engineering with scalable manufacturing and delivery solutions, RNArevive Therapeutics contributes to the advancement of RNA-based medicines. Collaborative efforts with academic and industry partners support the development of a versatile platform capable of addressing multiple therapeutic indications, positioning the company as an important innovator in the life sciences sector.
- Category
- Other
- Location
- Canada
- Checked
- 3h ago
RNARevive: questions
Which accelerators did RNARevive go through?
RNARevive is listed by Plug and Play.
Where is RNARevive based?
RNARevive lists Canada as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.